Record date for stock split determined
At Vitrolife AB’s Annual General Meeting on April 26, 2018 it was resolved to increase the number of shares in the company by dividing each share into five shares (stock split 5:1). The Board of Directors was authorized to determine the record date for the stock split.
The Board of Directors has now determined that the record date for the stock split will be Friday May 18, 2018, which means that the last day for trading in the share prior to the split is Wednesday May 16, 2018 and the first day for trading with the split shares is Thursday May 17, 2018.
As a result of the split, the shares in Vitrolife AB will as from and including May 17, 2018 change ISIN-number. The new ISIN number is SE0011205202. The shares obtained through the split are expected to be registered on VP-accounts on Monday May 21, 2018.
The split will be carried out automatically by Euroclear and shareholders do not need take any actions. After the split, the number of shares in the company will amount to 108 550 575.
Gothenburg, May 7, 2018
VITROLIFE AB (publ)
The Board
Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14
This information is information that Vitrolife AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.30 am CET on May 7, 2018.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
_________________________________________________________________________________________________________________
Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.
Vitrolife has approximately 370 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.
Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/
Tags: